Related references
Note: Only part of the references are listed.Synergy between Readthrough and Nonsense Mediated Decay Inhibition in a Murine Model of Cystic Fibrosis Nonsense Mutations
Daniel R. McHugh et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Therapeutic promise of engineered nonsense suppressor tRNAs
Joseph J. Porter et al.
WILEY INTERDISCIPLINARY REVIEWS-RNA (2021)
Effect of small molecule eRF3 degraders on premature termination codon readthrough
Alireza Baradaran-Heravi et al.
NUCLEIC ACIDS RESEARCH (2021)
Effect of Gentamicin Ointment in Patients with Nagashima-type Palmoplantar Keratosis: A Double-blind Vehicle-controlled Study
Yue Li et al.
ACTA DERMATO-VENEREOLOGICA (2021)
Effect of small molecule eRF3 degraders on premature termination codon readthrough
Alireza Baradaran-Heravi et al.
NUCLEIC ACIDS RESEARCH (2021)
Treatment of hereditary hypotrichosis simplex of the scalp with topical gentamicin
A. Peled et al.
BRITISH JOURNAL OF DERMATOLOGY (2020)
Mutation-Directed Therapeutics for Neurofibromatosis Type I
Andre Leier et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2020)
Suppression of Nonsense Mutations by New Emerging Technologies
Pedro Morais et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Engineered transfer RNAs for suppression of premature termination codons
John D. Lueck et al.
NATURE COMMUNICATIONS (2019)
Strategies against Nonsense: Oxadiazoles as Translational Readthrough-Inducing Drugs (TRIDs)
Ambra Campofelice et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Aminoglycoside drugs induce efficient read-through of CDKL5 nonsense mutations, slightly restoring its kinase activity
Maria Fazzari et al.
RNA BIOLOGY (2019)
Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives
Valentino Bezzerri et al.
MOLECULAR DIAGNOSIS & THERAPY (2019)
Topical Gentamicin for the Treatment of Genetic Skin Diseases
Anna M. G. Pasmooij
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Gentamicin-Induced Readthrough and Nonsense-Mediated mRNA Decay of SERPINB7 Nonsense Mutant Transcripts
Yuka Ohguchi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2018)
Advances in therapeutic use of a drug-stimulated translational readthrough of premature termination codons
Maciej Dabrowski et al.
MOLECULAR MEDICINE (2018)
Mechanism and evidence of nonsense suppression therapy for genetic eye disorders
Rose Richardson et al.
EXPERIMENTAL EYE RESEARCH (2017)
Gentamicin induces functional type VII collagen in recessive dystrophic epidermolysis bullosa patients
David T. Woodley et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Amlexanox Enhances Premature Termination Codon Read-Through in COL7A1 and Expression of Full Length Type VII Collagen: Potential Therapy for Recessive Dystrophic Epidermolysis Bullosa
Velina S. Atanasova et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2017)
Gentamicin B1 is a minor gentamicin component with major nonsense mutation suppression activity
Alireza Baradaran-Heravi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Aminoglycoside interactions and impacts on the eukaryotic ribosome
Irina Prokhorova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The nucleoside analog clitocine is a potent and efficacious readthrough agent
Westley J. Friesen et al.
RNA (2017)
Functional rescue of REP1 following treatment with PTC124 and novel derivative PTC-414 in human choroideremia fibroblasts and the nonsense-mediated zebrafish model
Mariya Moosajee et al.
HUMAN MOLECULAR GENETICS (2016)
Ataluren stimulates ribosomal selection of near-cognate tRNAs to promote nonsense suppression
Bijoyita Roy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Aminoglycosides: An Overview
Kevin M. Krause et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Functional Translational Readthrough: A Systems Biology Perspective
Fabian Schueren et al.
PLOS GENETICS (2016)
Nonsense-mediated mRNA decay: an intricate machinery that shapes transcriptomes
Soren Lykke-Andersen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2015)
Toward a Rationale for the PTC124 (Ataluren) Promoted Readthrough of Premature Stop Codons: A Computational Approach and GFP-Reporter Cell-Based Assay
Laura Lentini et al.
MOLECULAR PHARMACEUTICS (2014)
Aminoglycosides Restore Full-length Type VII Collagen by Overcoming Premature Termination Codons: Therapeutic Implications for Dystrophic Epidermolysis Bullosa
Jon Cogan et al.
MOLECULAR THERAPY (2014)
Premature Termination Codon Read-Through in the ABCC6 Gene: Potential Treatment for Pseudoxanthoma Elasticum
Yong Zhou et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2013)
A New Series of Small Molecular Weight Compounds Induce Read Through of All Three Types of Nonsense Mutations in the ATM Gene
Liutao Du et al.
MOLECULAR THERAPY (2013)
Repair of UV photolesions in xeroderma pigmentosum group C cells induced by translational readthrough of premature termination codons
Christiane Kuschal et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A Lack of Premature Termination Codon Read-Through Efficacy of PTC124 (Ataluren) in a Diverse Array of Reporter Assays
Stuart P. McElroy et al.
PLOS BIOLOGY (2013)
Suppression of premature termination codons as a therapeutic approach
Kim M. Keeling et al.
CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Read-through compound 13 restores dystrophin expression and improves muscle function in the mdx mouse model for Duchenne muscular dystrophy
Refik Kayali et al.
HUMAN MOLECULAR GENETICS (2012)
Pharmaceutical therapies to recode nonsense mutations in inherited diseases
Hui-Ling Rose Lee et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Truncating mutations in the last exon of NOTCH2 cause a rare skeletal disorder with osteoporosis
Bertrand Isidor et al.
NATURE GENETICS (2011)
Translational Read-through of a Nonsense Mutation in ATP7A Impacts Treatment Outcome in Menkes Disease
Stephen G. Kaler et al.
ANNALS OF NEUROLOGY (2009)
Nonaminoglycoside compounds induce readthrough of nonsense mutations
Liutao Du et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2009)
Development of Novel Aminoglycoside (NB54) with Reduced Toxicity and Enhanced Suppression of Disease-Causing Premature Stop Mutations
Igor Nudelman et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Nonsense-mediated mRNA decay (NMD) mechanisms
Saverio Brogna et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Translational bypass of nonsense mutations in zebrafish rep1, pax2.1 and lamb1 highlights a viable therapeutic option for untreatable genetic eye disease
Mariya Moosajee et al.
HUMAN MOLECULAR GENETICS (2008)
Designer aminoglycosides: the race to develop improved antibiotics and compounds for the treatment of human genetic diseases
Mariana Hainrichson et al.
ORGANIC & BIOMOLECULAR CHEMISTRY (2008)
PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model
Ming Du et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Introducing sense into nonsense in treatments of human genetic diseases
Liat Linde et al.
TRENDS IN GENETICS (2008)
In vitro and ex vivo suppression by aminoglycosides of PCDH15 nonsense mutations underlying type 1 Usher syndrome
Annie Rebibo-Sabbah et al.
HUMAN GENETICS (2007)
Autosomal recessive von Willebrand disease associated with compound heterozygosity for a novel nonsense mutation (2908 Del C) and the missense mutation C2362F: Definite evidence for the non-penetrance of the C2362F mutation
G. Castaman et al.
AMERICAN JOURNAL OF HEMATOLOGY (2007)
Safety, tolerability, and pharmacokinetics of PTC124, a nonaminoglycoside nonsense mutation suppressor, following single- and multiple-dose administration to healthy male and female adult volunteers
Samit Hirawat et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2007)
The human RNA surveillance factor UPF1 is required for S phase progression and genome stability
CM Azzalin et al.
CURRENT BIOLOGY (2006)
Aminoglycosides as potential pharmacogenetic agents in the treatment of Hailey-Hailey disease
Richard Kellermayer et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)
Effects of a number of classes of 50S inhibitors on stop codon readthrough during protein synthesis
J Thompson et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Correction of ATM gene function by aminoglycoside-induced read-through of premature termination codons
CH Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Aminoglycoside-mediated rescue of a disease-causing nonsense mutation in the V2 vasopressin receptor gene in vitro and in vivo
K Sangkuhl et al.
HUMAN MOLECULAR GENETICS (2004)
Negamycin restores dystrophin expression in skeletal and cardiac muscles of mdx mice
M Arakawa et al.
JOURNAL OF BIOCHEMISTRY (2003)
Expression of CTNS alleles:: Subcellular localization and aminoglycoside correction in vitro
A Helip-Wooley et al.
MOLECULAR GENETICS AND METABOLISM (2002)
In vitro analysis of aminoglycoside therapy for the Arg 120stop nonsense mutation in RP2 patients
C Grayson et al.
JOURNAL OF MEDICAL GENETICS (2002)
Suppression of nonsense mutations in the dystrophin gene by a suppressor tRNA gene
AV Kiselev et al.
MOLECULAR BIOLOGY (2002)
When the message goes awry: Disease-producing mutations that influence mRNA content and performance
JT Mendell et al.
CELL (2001)
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis
JP Clancy et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)
Premature termination mutations in exon 3 of the SMN1 gene are associated with exon skipping and a relatively mild SMA phenotype
V Sossi et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)
Gentamicin-mediated suppression of Hurler syndrome stop mutations restores a low level of α-L-iduronidase activity and reduces lysosomal glycosaminoglycan accumulation
KM Keeling et al.
HUMAN MOLECULAR GENETICS (2001)
Suppression of nonsense mutations in cell culture and mice by multimerized suppressor tRNA genes
M Buvoli et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
Share Paper
